Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-05-16

FDA Approved: LUCEMYRA — Original Application (USWM, LLC)

View source ↗

Summary

FDA approved LUCEMYRA (lofexidine hydrochloride) as an original NDA for reducing opioid withdrawal symptoms during detoxification.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LUCEMYRA (LOFEXIDINE HYDROCHLORIDE)

Snippet

ORIG AP for LUCEMYRA (LOFEXIDINE HYDROCHLORIDE)